To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:5 Issue:2 Number:1 ISSN#:2563-559X
OE Original

SARS-CoV-2 Omicron: What’s New in Evidence?

Authored By: Meng Zhu, Mohit Bhandari On Behalf of OrthoEvidence

February 7, 2022

How to Cite

OrthoEvidence. SARS-CoV-2 Omicron: What’s New in Evidence?. OE Original. 2022;5(2):1. Available from:

It is hard to imagine that the COVID-19 pandemic has been with us and impacted almost every aspect of our lives for the last 2 years. Everyone feels exhausted from this crisis and keeps asking when this pandemic will be over. Unfortunately, nobody can provide an exact answer. It is critical that we remain calm and continue to use evidence to guide our decisions. In this OE Original, we try to provide some answers to key questions about the SARS-CoV-2 Omicron variant of concern (VOC) (B.1.1.529). The Omicron variant has rapidly become the dominant SARS-CoV-2 strain on a global scale and outpaced the Delta variant in most countries. According to the World Health Organization (WHO), as of February 1, 2022, the Omicron VOC accounted for over.....
OE OriginalPreview Image

Please Login or Join to leave comments.